 |
Trial Information
Summary: Alzheimer's ResearchIf you or someone you care about has been diagnosed with Alzheimer's disease, they may qualify for a clinical research study of an investigational drug. Qualified participants must be age 45 to 90 and currently taking Aricept® (Donepezil) for at least the past 3 months. Qualified participants will receive study-related care at no cost and may be reimbursed for travel expenses. Call Mon-Fri for more information Patient Exclusion Criteria: Please contact for more information
This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials. Trial listings updated: June 1, 2008 at 6:45:30 AM |
|
|
Patient Resources: [ Trial Listing
] [ Notification Services ] [ Drug
Directories ]
Copyright © 1995 - 2008, CenterWatch |
